Related references
Note: Only part of the references are listed.Injectable Cryogels for Biomedical Applications
Loek J. Eggermont et al.
TRENDS IN BIOTECHNOLOGY (2020)
Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity
Gillie A. Roth et al.
ACS CENTRAL SCIENCE (2020)
A 3D Macroporous Alginate Graphene Scaffold with an Extremely Slow Release of a Loaded Cargo for In Situ Long-Term Activation of Dendritic Cells
Arjyabaran Sinha et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Acetalated Dextran Nanoparticles Loaded into an Injectable Alginate Cryogel for Combined Chemotherapy and Cancer Vaccination
Tomas Bauleth-Ramos et al.
ADVANCED FUNCTIONAL MATERIALS (2019)
Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor-Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy
Hathaichanok Phuengkham et al.
ADVANCED MATERIALS (2018)
Covalent Conjugation of Peptide Antigen to Mesoporous Silica Rods to Enhance Cellular Responses
Maxence O. Dellacherie et al.
BIOCONJUGATE CHEMISTRY (2018)
A facile approach to enhance antigen response for personalized cancer vaccination
Aileen Weiwei Li et al.
NATURE MATERIALS (2018)
Endolysosomal-Escape Nanovaccines through Adjuvant-Induced Tumor Antigen Assembly for Enhanced Effector CD8(+) T Cell Activation
Liping Qiu et al.
SMALL (2018)
Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and Delivery
Jorieke Weiden et al.
FRONTIERS IN IMMUNOLOGY (2018)
Synthetic immune niches for cancer immunotherapy
Jorieke Weiden et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity
Luis J. Cruz et al.
NANOMEDICINE (2017)
Dendritic Cells and Cancer Immunity
Alycia Gardner et al.
TRENDS IN IMMUNOLOGY (2016)
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
Christophe Macri et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Injectable cryogel-based whole-cell cancer vaccines
Sidi A. Bencherif et al.
NATURE COMMUNICATIONS (2015)
Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
Jaeyun Kim et al.
NATURE BIOTECHNOLOGY (2015)
Tumor cell lysates as immunogenic sources for cancer vaccine design
Fermin E. Gonzalez et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
pH-Responsive Nanoparticle Vaccines for Dual-Delivery of Antigens and Immunostimulatory Oligonucleotides
John T. Wilson et al.
ACS NANO (2013)
Colocalized Delivery of Adjuvant and Antigen Using Nanolipoprotein Particles Enhances the Immune Response to Recombinant Antigens
Nicholas O. Fischer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Yared Hailemichael et al.
NATURE MEDICINE (2013)
Injectable preformed scaffolds with shape-memory properties
Sidi A. Bencherif et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Paul J. Tacken et al.
BLOOD (2011)
Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity
Corbin Clawson et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients
Joannes F. M. Jacobs et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Infection-mimicking materials to program dendritic cells in situ
Omar A. Ali et al.
NATURE MATERIALS (2009)
Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN
Susan de Jong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
H Shen et al.
IMMUNOLOGY (2006)
Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease
B Ludewig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
